Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure

NCT ID: NCT04284462

Last Updated: 2020-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-14

Study Completion Date

2020-03-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calorie CSD consumers. Each cohort will be randomized to one of 3 interventions for six months (24 weeks):

* Intervention 1: Control (full sweetness) beverage
* Intervention 2: Step-wise sweetness reduction series of beverages
* Intervention 3: Moderate sweetness (reduced sweetness) beverage

The primary outcome is to assess the perception changes in sweetness (magnitude scale) and sweetness liking (Likert scale) of a test product and a control product over a period of six months. The study endeavors to explore whether consumers of sweetened carbonated beverages can adapt liking to lower sweetness beverages after prolonged exposure of daily consumption of beverages with step-wise reduction of sweetness, or maintenance at reduced (moderate) sweetness.

The secondary outcome will be to assess dietary compensation for sweetness in the step-wise and moderate reduction arms compared to the control arms (the full calorie and low calorie control beverages). Dietary analysis of calories and intakes of total sugar, added sugar, and servings of low-/non-calorie sweeteners will be assessed using a 3-day diet record pre-intervention and monthly for 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sweetness Liking Adaptation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Same packaging for all (cans). Color and flavor matched.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control beverage for Habitual full-calorie CSD cohort, n=28

Full sweetness (sugar) for 6 months

Group Type PLACEBO_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Control beverage for Habitual low-calorie CSD cohort, n=28

Full sweetness low calorie sweetener (LCS) with sweetness level matched to the full sweetness sugar control for 6 months

Group Type PLACEBO_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Test beverage 1 for Habitual full-calorie CSD cohort, n=28

Reduced sweetness (moderate sugar level) for 6 months

Group Type ACTIVE_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Test beverage 1 for Habitual low-calorie CSD cohort, n=28

Reduced sweetness low calorie sweetener (LCS) with sweetness level matched to the moderate sugar sweetness level for 6 months

Group Type ACTIVE_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Test beverage 2 for Habitual full-calorie CSD cohort, n=28

Step-wise sweetness reduction over 6 months. Month 1 is the full sweetness sugar control, followed by monthly sweetness reduction. Remains at the reduced sweetness level (moderate sugar level) from months 4-6.

Group Type ACTIVE_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Test beverage 2 for Habitual low-calorie CSD cohort, n=28

Step-wise sweetness reduction over 6 months. Month 1 is the low calorie sweetener (LCS) sweetness equivalent of the full sweetness sugar control, followed by monthly LCS sweetness reduction (reductions equivalent to the corresponding sugar reduction arm sweetness levels). Remains at the reduced sweetness level (LCS equivalent of moderate sugar sweetness level) from months 4-6.

Group Type ACTIVE_COMPARATOR

Flavored carbonated soft drink (CSD)

Intervention Type OTHER

1-2 cans/day (330 ml per can)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Flavored carbonated soft drink (CSD)

1-2 cans/day (330 ml per can)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy adults 25-55 years of age
2. Habitually consume regular or diet carbonated soft drinks (CSD)
3. Willing and able to consume at least one CSD beverage daily for a total of 6 months and abstain from other sweetened beverages
4. Willing and able to complete questionnaires regarding dietary intake and sensory perception
5. Has internet access via computer, phone or other device and is able to maintain internet access throughout the trial in order to complete daily online questionnaires.
6. Participant is judged to be in good health on the basis of medical history and the general health and lifestyle questionnaire.
7. Participant is willing to maintain his or her habitual diet, smoking habits and physical activity patterns, including habitual use of study approved medications and/or dietary supplements throughout the study period.
8. Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.

Exclusion Criteria

1. Regular smoker (more than 1 cigarette per week)
2. History or presence of clinically important endocrine (including type 1 or 2 diabetes mellitus), cardiovascular, pulmonary, biliary, renal, hepatic, pancreatic, or neurologic disorders that, in the opinion of the Clinical Investigator, could interfere with the interpretation of the study results.
3. Extreme dietary habits, including but not limited to vegetarian diets and intentional consumption of a high fiber diet, gluten-free, low-carb, vegan, ketogenic.
4. Extreme changes to physical activity
5. Females who are pregnant, planning to be pregnant during the study period, lactating, or of childbearing potential and unwilling to commit to the use of a medically approved form of contraception throughout the study period.
6. Recent history (within 12 months of screening; Visit 1) of alcohol or substance abuse. Alcohol abuse is defined as \>14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
7. Individual has a condition the Clinical Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put the participant at undue risk.
8. Dislike of study product taste
9. Participation in another clinical trial within past 30 days and participation in a PepsiCo clinical trial in the past 6 months.
10. People who have phenylketonuria (low calorie sweetened beverages contain aspartame)
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kathleen Kelley, MD

Role: PRINCIPAL_INVESTIGATOR

Biofortis Innovation Services

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

BioFortis Innovation Services

Addison, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP-1908

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sugary Drink Labeling Study
NCT07294053 NOT_YET_RECRUITING NA